{"id":582268,"date":"2026-05-22T14:12:10","date_gmt":"2026-05-22T17:12:10","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=582268"},"modified":"2026-05-22T14:40:04","modified_gmt":"2026-05-22T17:40:04","slug":"innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/","title":{"rendered":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Asunci\u00f3n, Agencia IP.-<\/strong><\/em> La Facultad de Ciencias M\u00e9dicas de la Universidad Nacional de Asunci\u00f3n, Hospital de Cl\u00ednicas,\u00a0 forma parte del consorcio Cart &#8211; Nel, un proyecto liderado por la Cl\u00ednica Universidad de Navarra, Espa\u00f1a, que busca avanzar en el desarrollo de terapias para tratar la Nefritis L\u00fapica Refractaria.<\/p>\n<p style=\"text-align: justify;\"><!--more--><\/p>\n<p>Hasta el momento, beneficia a 4 pacientes de Paraguay, de las cuales uno ya lleva ya seis meses de tratamiento con muy buena respuesta cl\u00ednica y sin efectos secundarios importantes.<\/p>\n<p style=\"text-align: justify;\">En el marco del proyecto de investigaci\u00f3n, y a trav\u00e9s de un convenio de cooperaci\u00f3n, se busca dar la oportunidad a pacientes de Latinoam\u00e9rica a recibir este novedoso tratamiento.<\/p>\n<p style=\"text-align: justify;\">Hasta el momento, el Servicio de Nefrolog\u00eda y Reumatolog\u00eda de la Facultad de Ciencias M\u00e9dicas, conjuntamente con la Cl\u00ednica Universidad de Navarra, impulsan el esperanzador tratamiento a cuatro pacientes del Paraguay, de las cuales una de ellas lleva ya seis meses de tratamiento con muy buena respuesta cl\u00ednica y sin efectos secundarios importantes.<\/p>\n<p style=\"text-align: justify;\"><strong>Proyecto Cart-Nel <\/strong><\/p>\n<p style=\"text-align: justify;\">El Proyecto Cart-Nel es un ensayo cl\u00ednico acad\u00e9mico impulsado por la Cl\u00ednica Universidad de Navarra, Espa\u00f1a, con el doble objetivo de ofrecer terapia celular avanzada a pacientes con lupus refractario de forma accesible, independientemente de su situaci\u00f3n econ\u00f3mica o social; adem\u00e1s de formar profesionales en Espa\u00f1a y en otros pa\u00edses para que puedan llevar estas terapias a sus lugares de origen.<\/p>\n<p style=\"text-align: justify;\">El Dr. Jos\u00e9 Mar\u00eda Mora, investigador principal del estudio y nefr\u00f3logo de la Cl\u00ednica Universidad de Navarra, explica que el ensayo est\u00e1 destinado a pacientes que sufran lupus con o sin afectaci\u00f3n renal. Hasta ahora, las enfermedades autoinmunes severas no ten\u00edan una verdadera opci\u00f3n terap\u00e9utica a largo plazo.<\/p>\n<p style=\"text-align: justify;\">El proyecto Cart-Nel \u00a0pretende que estas pacientes de Latinoam\u00e9rica, independientemente de su origen, puedan tener una opci\u00f3n viable para su tratamiento y el desarrollo de la medicina en los pa\u00edses que forman parte del consorcio.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Asunci\u00f3n, Agencia IP.- La Facultad de Ciencias M\u00e9dicas de la Universidad Nacional de Asunci\u00f3n, Hospital de Cl\u00ednicas,\u00a0 forma parte del consorcio Cart &#8211; Nel, un proyecto liderado por la Cl\u00ednica Universidad de Navarra, Espa\u00f1a, que busca avanzar en el desarrollo de terapias para tratar la Nefritis L\u00fapica Refractaria.<\/p>\n","protected":false},"author":42,"featured_media":582272,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2987],"tags":[],"class_list":["post-582268","post","type-post","status-publish","format-standard","has-post-thumbnail","category-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Asunci\u00f3n, Agencia IP.- La Facultad de Ciencias M\u00e9dicas de la Universidad Nacional de Asunci\u00f3n, Hospital de Cl\u00ednicas,\u00a0 forma parte del consorcio Cart &#8211; Nel, un proyecto liderado por la Cl\u00ednica Universidad de Navarra, Espa\u00f1a, que busca avanzar en el desarrollo de terapias para tratar la Nefritis L\u00fapica Refractaria.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-22T17:12:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T17:40:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"C\u00e1ndida Ocampos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"C\u00e1ndida Ocampos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/\"},\"author\":{\"name\":\"C\u00e1ndida Ocampos\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/41ab58f25c1eed7a83bfa01c4f9d3baf\"},\"headline\":\"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay\",\"datePublished\":\"2026-05-22T17:12:10+00:00\",\"dateModified\":\"2026-05-22T17:40:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/FCMUNA-CLINICAS.jpg\",\"articleSection\":[\"Salud\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/\",\"name\":\"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/FCMUNA-CLINICAS.jpg\",\"datePublished\":\"2026-05-22T17:12:10+00:00\",\"dateModified\":\"2026-05-22T17:40:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/FCMUNA-CLINICAS.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/FCMUNA-CLINICAS.jpg\",\"width\":1600,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2026\\\/05\\\/22\\\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/41ab58f25c1eed7a83bfa01c4f9d3baf\",\"name\":\"C\u00e1ndida Ocampos\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/cocampos\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/","og_locale":"es_ES","og_type":"article","og_title":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.","og_description":"Asunci\u00f3n, Agencia IP.- La Facultad de Ciencias M\u00e9dicas de la Universidad Nacional de Asunci\u00f3n, Hospital de Cl\u00ednicas,\u00a0 forma parte del consorcio Cart &#8211; Nel, un proyecto liderado por la Cl\u00ednica Universidad de Navarra, Espa\u00f1a, que busca avanzar en el desarrollo de terapias para tratar la Nefritis L\u00fapica Refractaria.","og_url":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2026-05-22T17:12:10+00:00","article_modified_time":"2026-05-22T17:40:04+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg","type":"image\/jpeg"}],"author":"C\u00e1ndida Ocampos","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"C\u00e1ndida Ocampos","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/"},"author":{"name":"C\u00e1ndida Ocampos","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/41ab58f25c1eed7a83bfa01c4f9d3baf"},"headline":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay","datePublished":"2026-05-22T17:12:10+00:00","dateModified":"2026-05-22T17:40:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/"},"wordCount":362,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg","articleSection":["Salud"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/","url":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/","name":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg","datePublished":"2026-05-22T17:12:10+00:00","dateModified":"2026-05-22T17:40:04+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2026\/05\/FCMUNA-CLINICAS.jpg","width":1600,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2026\/05\/22\/innovacion-medica-de-terapia-celular-liderado-por-clinica-de-universidad-de-navarra-beneficia-a-4-pacientes-de-paraguay\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Innovaci\u00f3n m\u00e9dica de terapia celular liderado por Cl\u00ednica de Universidad de Navarra beneficia a 4 pacientes de Paraguay"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/41ab58f25c1eed7a83bfa01c4f9d3baf","name":"C\u00e1ndida Ocampos","url":"https:\/\/www.ip.gov.py\/ip\/author\/cocampos\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/582268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=582268"}],"version-history":[{"count":2,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/582268\/revisions"}],"predecessor-version":[{"id":582281,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/582268\/revisions\/582281"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/582272"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=582268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=582268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=582268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}